Cardinal Health (NYSE:CAH) Reports Upbeat Q3, Stock Jumps 10.7%

Cardinal Health's Q3 results surpassed expectations, with a 22% year-on-year sales increase to $64.01 billion and adjusted profit of $2.55 per share, beating estimates by 17%. The company's revenue growth of nearly 8% and raised full-year earnings guidance signal optimism. However, flat operating margins and cost management challenges persist. Despite these, the company's stock price rose over 10% post-results, reflecting investor confidence. Cardinal Health's Q3 performance indicates strong growth and demand, but the company must address cost management to sustain its positive trajectory.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.